Minitouch 3.8 Era System (Minitouch System)
MICROCUBE, LLC · Decision date Jul 13, 2026
What did the FDA approve?
FDA records P230002/S002 as a supplement to PMA P230002, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Jul 13, 2026.
FDA approval order statement
Approval for design modifications to the Minitouch System, including changes to the Handpiece manufacturing methods and changes to the Generator system architecture, hardware, and software to add additional risk control measures and provide an updated user interface.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Obstetrics/Gynecology
- Decision date
- Jul 13, 2026
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P230002/S002
- Regulatory pathway
- PMA supplement
- Applicant
- MICROCUBE, LLC
- Product code
- MNB
- Decision code
- APPR
- Decision date
- Jul 13, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Device, thermal ablation, endometrial.
- Applicant
- MICROCUBE, LLC
- Product code
- MNB
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P230002/S002 received
Application receipt date recorded by FDA.
P230002/S002 · FDA decision
Normal 180 Day Track
Timeline entries are records held by MedtechLedger for P230002. View FDA’s full supplement list.
Related devices and submissions
Explore the linked device profile
Other records with product code MNB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MINERVA ENDOMETRIAL ABLATION SYSTEMP140013/S019 | Axora Medical, Inc. | PMA supplement | Nov 5, 2026 | FDA |
| Channel Medsystems, Inc. | PMA supplement | Nov 3, 2026 | FDA | |
Cerene Cryotherapy DeviceP180032/S024 | Channel Medsystems, Inc. | PMA supplement | Sep 15, 2026 | FDA |
Cerene Cryotherapy DeviceP180032/S023 | Channel Medsystems, Inc. | PMA supplement | Jul 8, 2026 | FDA |
Minerva Endometrial Ablation SystemP140013/S018 | Axora Medical, Inc. | PMA supplement | Feb 12, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
MICROCUBE, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 47853 Warm Springs Blvd., Fremont, CA, 94539
Sources and methodology
- Original FDA record: P230002/S002
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


